Published Online: Monday, March 1, 2004

Doak Dermatologics (Fairfield, NJ), a subsidiary of Bradley Pharmaceuticals Inc, has announced the introduction of a new prescription-only topical acne treatment, Zoderm. Zoderm contains benzoyl peroxide in a special moisturizing base of 10% urea. The product is available in gel, cream, and cleanser form in 4.5% (for mild acne) and 8.5% (for moderate-to-severe acne) strengths of benzoyl peroxide. The Zoderm family of treatments represents an innovative departure from traditional benzoyl peroxide acne therapies, resulting in excellent tolerability, even in patients with sensitive skin. For more information, visit www.doakderm.com, or call 800-405- DOAK (800-405-3625).

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues